Clinical trial
Shock Trial: Should We Emergently Revascularize Occluded Coronaries for…
NCT00000552 · Carelon Research, Other · Completed
Key facts
| NCT number | NCT00000552 |
|---|---|
| Title | Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. |
| Lead sponsor | Carelon Research, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia, Shock, Cardiogenic |
| Intervention type | Drug, Procedure |
| Interventions | angioplasty, transluminal, percutaneous coronary, coronary artery bypass, thrombolytic therapy |
| Start date | Sep 1, 1994 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 28, 1999 |
| Last update posted | Mar 4, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: